We further confirmed the abnormal expression of FDX1, SUMF1, and SLC31A1 proteins in glioma samples by immunohistochemistry, and the correlation between high expression of FDX1 protein and poor prognosis in glioma patients. The gene discussed is SLC31A1; the disease is central nervous system cancer.